Subscribe here to receive future editions. AstraZeneca said it is doubling down on its investment in its U.S. business, a ...
AstraZeneca’s earnings were boosted by its oncology, cardiovascular, respiratory and immunology (R&I), and rare disease ...
Hosted on MSN17h
AstraZeneca Expands U.S. Investment PlanAstraZeneca said it plans to pump $2 billion in new investment into the U.S., one of the first major foreign companies to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback